Meningococcal (Men B)

Meningococcal Serogroup B  (aka Trumenba or Bexsero)

Recommended between 16 to 18 years of age

16 years(if local outbreak; absent or damaged spleen; complement deficiency)

16-17 years  (1 month after first dose)